Branded Generics Market Showing Global CAGR of 7.5% Upto 2024 with Companies Analysis Like Teva, Novartis, Mylan, Abbott, Actavis, Sun, Allergan, STADA and More
The Branded Generics Market accounted to USD 190.3 billion in 2016 growing at a CAGR of 7.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
View full press release